SCHEMBL25436610

SCHEMBL25436610

COc1cc(C)cc2[nH]cc(C(=O)C(=O)N(C)C(C)C)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 2/20 0.36
▸ KCNH2 Q12809 1/20 0.32
▸ MTNR1A P48039 1/20 0.31
▸ MTNR1B P49286 1/20 0.31
▸ MAPK14 Q16539 1/20 0.31
▸ TUBB1 Q9H4B7 1/20 0.31
▸ GABRP O00591 1/20 0.31
▸ GABRD O14764 1/20 0.31
▸ GABRA1 P14867 1/20 0.31
▸ GABRB1 P18505 1/20 0.31
▸ GABRG2 P18507 1/20 0.31
▸ GABRB3 P28472 1/20 0.31
▸ GABRA5 P31644 1/20 0.31
▸ GABRA3 P34903 1/20 0.31
▸ GABRA2 P47869 1/20 0.31
▸ GABRB2 P47870 1/20 0.31
▸ GABRA4 P48169 1/20 0.31
▸ GABRE P78334 1/20 0.31
▸ GABRA6 Q16445 1/20 0.31
▸ GABRG1 Q8N1C3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25423409 0.89 NR4A2 (0.36) NR4A2KCNH2MTNR1AMTNR1BMAPK14
SCHEMBL25438139 0.87 NR4A2 (0.39) NR4A2KCNH2MTNR1AMTNR1BMAPK14
SCHEMBL25424226 0.87 MAPK14 (0.36) MAPK14TUBB1
SCHEMBL25748328 0.83 NR4A2 (0.36) NR4A2KCNH2MTNR1AMTNR1BMAPK14
SCHEMBL25748334 0.81 CYP1A2 (0.36) NR4A2KCNH2GABRPGABRDGABRA1
SCHEMBL25747864 0.81 HTR1A (0.35) NR4A2MTNR1AMTNR1B
SCHEMBL25424327 0.79 NR4A2 (0.40) NR4A2KCNH2TUBB1GABRPGABRD
SCHEMBL25747919 0.78 MAPK14 (0.38) NR4A2MTNR1AMTNR1BMAPK14TUBB1
SCHEMBL17417628 0.77 NR4A2 (0.43) NR4A2
SCHEMBL25422956 0.77 HTR1A (0.47) MTNR1AMTNR1BMAPK14GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB NR4A2 3254/4885KCNH2 2136/4885MTNR1A 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback